{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,29]],"date-time":"2026-09-29T18:49:01Z","timestamp":1790707741366,"version":"4.1.0"},"reference-count":40,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2014,11,1]],"date-time":"2014-11-01T00:00:00Z","timestamp":1414800000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["European Journal of Pharmaceutics and Biopharmaceutics"],"published-print":{"date-parts":[[2014,11]]},"DOI":"10.1016\/j.ejpb.2014.08.012","type":"journal-article","created":{"date-parts":[[2014,9,6]],"date-time":"2014-09-06T17:31:00Z","timestamp":1410024660000},"page":"683-694","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":21,"title":["Self-assembled biotransesterified cyclodextrins as potential Artemisinin nanocarriers. II: In vitro behavior toward the immune system and in vivo biodistribution assessment of unloaded nanoparticles"],"prefix":"10.1016","volume":"88","author":[{"given":"Josias B.G.","family":"Yam\u00e9ogo","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Annabelle","family":"G\u00e8ze","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Luc","family":"Choisnard","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jean-Luc","family":"Putaux","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Roseline","family":"Mazet","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Catherine","family":"Passirani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michelle","family":"Keramidas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jean-Luc","family":"Coll","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nolwenn","family":"Lautram","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J\u00e9r\u00f4me","family":"Bejaud","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rasman\u00e9","family":"Semd\u00e9","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Denis","family":"Wouessidjewe","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ejpb.2014.08.012_b0005","unstructured":"World Health Organization (WHO), The Use of Antimalarial Drugs: Report of a WHO Informal Consultation 13\u201317 November, 2001 (WHO\/CS\/RBM\/2001.33)."},{"key":"10.1016\/j.ejpb.2014.08.012_b0010","first-page":"199","article-title":"Artemisinin drugs in the treatment of malaria: from medicinal herb to registered medication","volume":"20","author":"Van Agtmael","year":"1999","journal-title":"TiPS"},{"key":"10.1016\/j.ejpb.2014.08.012_b0015","doi-asserted-by":"crossref","first-page":"1035","DOI":"10.1081\/DDC-120025460","article-title":"Inclusion complexation of artemisinin with \u03b1-, \u03b2- and \u03b3-cyclodextrins","volume":"29","author":"Wong","year":"2003","journal-title":"Drug Dev. Ind. Pharm."},{"key":"10.1016\/j.ejpb.2014.08.012_b0020","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1016\/S0378-5173(01)00796-7","article-title":"Improved oral bioavailability of artemisinin through inclusion complexation \u03b2- and \u03b3-cyclodextrins","volume":"227","author":"Wong","year":"2001","journal-title":"Int. J. Pharm."},{"issue":"1","key":"10.1016\/j.ejpb.2014.08.012_b0025","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1002\/jps.21399","article-title":"Solubility enhancement of poorly water-soluble antimalarial drug: experimental design and use of a modified multifluid nozzle pilot spray drier","volume":"98","author":"Sahoo","year":"2009","journal-title":"J. Pharm. Sci."},{"issue":"3","key":"10.1016\/j.ejpb.2014.08.012_b0030","doi-asserted-by":"crossref","first-page":"237","DOI":"10.3109\/08982104.2010.539185","article-title":"Conventional and long-circulating liposomes of artemisinin: preparation, characterization, and pharmacokinetic profile in mice.","volume":"21","author":"Isacchi","year":"2011","journal-title":"J. Liposome Res."},{"issue":"3","key":"10.1016\/j.ejpb.2014.08.012_b0035","doi-asserted-by":"crossref","first-page":"528","DOI":"10.1016\/j.ejpb.2011.11.015","article-title":"Artemisinin and artemisinin plus curcumin liposomal formulations: enhanced antimalarial efficacy against Plasmodium berghei-infected mice","volume":"80","author":"Isacchi","year":"2012","journal-title":"Eur. J. Pharm. Biopharm."},{"issue":"3","key":"10.1016\/j.ejpb.2014.08.012_b0040","doi-asserted-by":"crossref","first-page":"508","DOI":"10.1016\/j.ejpb.2011.12.007","article-title":"Self-assembled biotransesterified cyclodextrins as Artemisinin nanocarriers. I: Formulation, lyoavailability and in vitro antimalarial activity assessment","volume":"80","author":"Yam\u00e9ogo","year":"2012","journal-title":"Eur. J. Pharm. Biopharm."},{"issue":"8","key":"10.1016\/j.ejpb.2014.08.012_b0045","doi-asserted-by":"crossref","first-page":"3031","DOI":"10.1021\/bm2006664","article-title":"Physicochemical characterization of \u03b1-, \u03b2- and \u03b3-cyclodextrins bioesterified with decanoate chains used as building blocks of colloidal nanoparticles","volume":"12","author":"Choisnard","year":"2011","journal-title":"Biomacromolecules"},{"key":"10.1016\/j.ejpb.2014.08.012_b0050","doi-asserted-by":"crossref","first-page":"515","DOI":"10.1021\/bm0507655","article-title":"Novel nanoparticles of \u03b2-cyclodextrin esters obtained by self-assembling of bio-transesterified \u03b2-cyclodextrins","volume":"7","author":"Choisnard","year":"2006","journal-title":"Biomacromolecules"},{"key":"10.1016\/j.ejpb.2014.08.012_b0055","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1016\/j.ijpharm.2007.06.026","article-title":"Miscellaneous nanoaggregates made of CD esters synthesised by an enzymatic pathway","volume":"344","author":"Choisnard","year":"2007","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.ejpb.2014.08.012_b0060","doi-asserted-by":"crossref","first-page":"458","DOI":"10.1016\/j.msec.2008.08.027","article-title":"Colloidal systems made of biotransesterified cyclodextrins grafted with C10 alkyl chains","volume":"29","author":"G\u00e8ze","year":"2009","journal-title":"Mater. Sci. Eng. C"},{"key":"10.1016\/j.ejpb.2014.08.012_b0065","doi-asserted-by":"crossref","first-page":"526","DOI":"10.2174\/1568026613666131219125135","article-title":"Progress in developing amphiphilic cyclodextrin-based nanodevices for drug delivery","volume":"14","author":"Yam\u00e9ogo","year":"2014","journal-title":"Curr. Top. Med. Chem."},{"issue":"7","key":"10.1016\/j.ejpb.2014.08.012_b0070","doi-asserted-by":"crossref","first-page":"1417","DOI":"10.1007\/s11095-006-0284-8","article-title":"Nanotechnology: intelligent design to treat complex disease","volume":"27","author":"Couvreur","year":"2006","journal-title":"Pharm. Res."},{"issue":"1-2","key":"10.1016\/j.ejpb.2014.08.012_b0075","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1016\/j.ijpharm.2007.06.050","article-title":"Biodistribution of intravenously administrated amphiphilic \u03b2-cyclodextrin nanospheres","volume":"344","author":"G\u00e8ze","year":"2007","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.ejpb.2014.08.012_b0080","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1016\/S0031-6997(24)01494-7","article-title":"Long-circulating and target-specific nanoparticles: theory and practice","volume":"53","author":"Moghimi","year":"2001","journal-title":"Pharmacol. Rev."},{"key":"10.1016\/j.ejpb.2014.08.012_b0085","doi-asserted-by":"crossref","first-page":"463","DOI":"10.1016\/S0163-7827(03)00033-X","article-title":"Stealth liposomes and long circulating nanoparticles: critical issues in pharmacokinetics, opsonization and protein-binding properties","volume":"42","author":"Moghimi","year":"2003","journal-title":"Prog. Lipid Res."},{"issue":"24","key":"10.1016\/j.ejpb.2014.08.012_b0090","doi-asserted-by":"crossref","first-page":"4356","DOI":"10.1016\/j.biomaterials.2006.03.039","article-title":"Parameters influencing the stealthiness of colloidal drug delivery systems","volume":"27","author":"Vonarbourg","year":"2006","journal-title":"Biomaterials"},{"issue":"8","key":"10.1016\/j.ejpb.2014.08.012_b0095","doi-asserted-by":"crossref","first-page":"775","DOI":"10.1016\/S0024-3205(97)01175-2","article-title":"Interactions of nanoparticles bearing heparin or dextran covalently bound to poly(methyl methacrylate) with the complement system","volume":"62","author":"Passirani","year":"1998","journal-title":"Life Sci."},{"key":"10.1016\/j.ejpb.2014.08.012_b0100","doi-asserted-by":"crossref","first-page":"411","DOI":"10.1023\/A:1010031605547","article-title":"Measurement of the density of polymeric nanoparticulate drug carriers by isopycnic centrifugation","volume":"1","author":"Vauthier","year":"1999","journal-title":"J. Nanopart. Res."},{"key":"10.1016\/j.ejpb.2014.08.012_b0105","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1016\/S0378-4347(99)00185-1","article-title":"Rapid determination of artemisinin and related analogues using high-performance liquid chromatography and an evaporative light scattering detector","volume":"730","author":"Avery","year":"1999","journal-title":"J. Chromatogr. B"},{"issue":"2","key":"10.1016\/j.ejpb.2014.08.012_b0110","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1016\/j.biomaterials.2009.09.044","article-title":"Long-circulating DNA lipid nanocapsules as new vector for passive tumor targeting","volume":"31","author":"Morille","year":"2010","journal-title":"Biomaterials"},{"issue":"7","key":"10.1016\/j.ejpb.2014.08.012_b0115","doi-asserted-by":"crossref","first-page":"1710","DOI":"10.1158\/1535-7163.MCT-06-0289","article-title":"A new generation of anticancer, drug-loaded, colloidal vectors reverses multidrug resistance in glioma and reduces tumor progression in rats","volume":"5","author":"Garcion","year":"2005","journal-title":"Mol. Cancer Ther."},{"issue":"9","key":"10.1016\/j.ejpb.2014.08.012_b0120","doi-asserted-by":"crossref","first-page":"2190","DOI":"10.1007\/s11095-006-9061-y","article-title":"Pegylated nanocapsules produced by an organic solvent-free method: evaluation of their stealth properties","volume":"23","author":"B\u00e9duneau","year":"2006","journal-title":"Pharm. Res."},{"issue":"3","key":"10.1016\/j.ejpb.2014.08.012_b0125","doi-asserted-by":"crossref","first-page":"620","DOI":"10.1002\/jbm.a.30711","article-title":"Evaluation of pegylated lipid nanocapsules versus complement system activation and macrophage uptake","volume":"78","author":"Vonarbourg","year":"2006","journal-title":"J. Biomed. Mater. Res. A"},{"issue":"1","key":"10.1016\/j.ejpb.2014.08.012_b0130","doi-asserted-by":"crossref","first-page":"126","DOI":"10.1007\/s11095-009-9986-z","article-title":"Positively-charged, porous, polysaccharide nanoparticles loaded with anionic molecules behave as stealth cationic nanocarriers","volume":"27","author":"Paillard","year":"2010","journal-title":"Pharm. Res."},{"key":"10.1016\/j.ejpb.2014.08.012_b0135","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1016\/j.ijpharm.2009.05.034","article-title":"Drug development in oncology assisted by noninvasive optical imaging","volume":"379","author":"Sancey","year":"2009","journal-title":"Int. J. Pharm."},{"issue":"5","key":"10.1016\/j.ejpb.2014.08.012_b0140","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1117\/1.3213606","article-title":"Cyanine-loaded lipid nanoparticles for improved in vivo fluorescence imaging","volume":"14","author":"Texier","year":"2009","journal-title":"J. Biomed. Opt."},{"issue":"12","key":"10.1016\/j.ejpb.2014.08.012_b0145","doi-asserted-by":"crossref","first-page":"2266","DOI":"10.1016\/j.bbamem.2010.03.016","article-title":"Optical small animal imaging in the drug discovery process","volume":"1798","author":"Dufort","year":"2010","journal-title":"Biochim. Biophys. Acta"},{"issue":"2","key":"10.1016\/j.ejpb.2014.08.012_b0150","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1016\/j.ejpb.2010.02.007","article-title":"Tumor targeting of functionalized lipid nanoparticles: assessment by in vivo fluorescence imaging","volume":"75","author":"Goutayer","year":"2010","journal-title":"Eur. J. Pharm. Biopharm."},{"key":"10.1016\/j.ejpb.2014.08.012_b0155","doi-asserted-by":"crossref","first-page":"2565","DOI":"10.1002\/smll.200900563","article-title":"Control of the in vivo biodistribution of hybrid nanoparticles with different poly(ethylene glycol) coatings","volume":"5","author":"Faure","year":"2009","journal-title":"Small"},{"key":"10.1016\/j.ejpb.2014.08.012_b0160","doi-asserted-by":"crossref","first-page":"2066","DOI":"10.1002\/elps.200410145","article-title":"Electrokinetic properties of noncharged lipid nanocapsules: influence of the dipolar distribution at the interface","volume":"26","author":"Vonarbourg","year":"2005","journal-title":"Electrophoresis"},{"issue":"2","key":"10.1016\/j.ejpb.2014.08.012_b0165","doi-asserted-by":"crossref","first-page":"2327","DOI":"10.1016\/j.biomaterials.2010.11.063","article-title":"Tumor transfection after systemic injection of DNA lipid nanocapsules","volume":"31","author":"Morille","year":"2011","journal-title":"Biomaterials"},{"key":"10.1016\/j.ejpb.2014.08.012_b0170","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1016\/j.ijpharm.2007.06.051","article-title":"Safety and efficacy of amphiphilic beta-cyclodextrin nanoparticles for paclitaxel delivery","volume":"347","author":"Bilensoy","year":"2008","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.ejpb.2014.08.012_b0175","doi-asserted-by":"crossref","first-page":"374","DOI":"10.1016\/j.biomaterials.2008.09.035","article-title":"The intracellular effects of non-ionic amphiphilic cyclodextrin nanoparticles in the delivery of anticancer drugs","volume":"30","author":"Quaglia","year":"2009","journal-title":"Biomaterials"},{"key":"10.1016\/j.ejpb.2014.08.012_b0180","doi-asserted-by":"crossref","first-page":"585","DOI":"10.1211\/jpp.58.5.0002","article-title":"Cytotoxic evaluation of injectable cyclodextrin nanoparticles","volume":"58","author":"Memisoglu-Bilensoy","year":"2006","journal-title":"J. Pharm. Pharmacol."},{"key":"10.1016\/j.ejpb.2014.08.012_b0185","doi-asserted-by":"crossref","first-page":"976","DOI":"10.1016\/j.addr.2011.05.010","article-title":"Advances in assay of complement function and activation","volume":"63","author":"Harboe","year":"2011","journal-title":"Adv. Drug Deliv. Rev."},{"key":"10.1016\/j.ejpb.2014.08.012_b0190","doi-asserted-by":"crossref","first-page":"1000","DOI":"10.1016\/j.addr.2011.06.002","article-title":"Material properties in complement activation","volume":"63","author":"Moghimi","year":"2011","journal-title":"Adv. Drug Deliv. Rev."},{"issue":"9","key":"10.1016\/j.ejpb.2014.08.012_b0195","doi-asserted-by":"crossref","first-page":"1415","DOI":"10.2217\/nnm.10.113","article-title":"The rise and rise of stealth nanocarriers for cancer therapy: passive versus active targeting","volume":"5","author":"Huynh","year":"2010","journal-title":"Nanomedicine"},{"key":"10.1016\/j.ejpb.2014.08.012_b0200","doi-asserted-by":"crossref","first-page":"1575","DOI":"10.1016\/0142-9612(95)00322-3","article-title":"Effect of PEO surface density on long circulating PLA-PEO nanoparticles which are very low complement activators","volume":"17","author":"Vittaz","year":"1996","journal-title":"Biomaterials"}],"container-title":["European Journal of Pharmaceutics and Biopharmaceutics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0939641114002677?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0939641114002677?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,5,4]],"date-time":"2025-05-04T14:21:25Z","timestamp":1746368485000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0939641114002677"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,11]]},"references-count":40,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2014,11]]}},"alternative-id":["S0939641114002677"],"URL":"https:\/\/doi.org\/10.1016\/j.ejpb.2014.08.012","relation":{},"ISSN":["0939-6411"],"issn-type":[{"value":"0939-6411","type":"print"}],"subject":[],"published":{"date-parts":[[2014,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Self-assembled biotransesterified cyclodextrins as potential Artemisinin nanocarriers. II: In vitro behavior toward the immune system and in vivo biodistribution assessment of unloaded nanoparticles","name":"articletitle","label":"Article Title"},{"value":"European Journal of Pharmaceutics and Biopharmaceutics","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ejpb.2014.08.012","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2014 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}